Clinical Trials Logo

Lidocaine clinical trials

View clinical trials related to Lidocaine.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06355817 Completed - Surgery Clinical Trials

Distraction Techniques in Periocular Anesthesia: Tapping vs Vibration

Start date: September 21, 2023
Phase: N/A
Study type: Interventional

To compare the efficacy of topical tapping vs vibration in lowering pain scores for periocular anesthesia injections.

NCT ID: NCT06184282 Completed - Lidocaine Clinical Trials

Topical Mebo Versus Lidocane in Healing Time of Traumatic Oral Ulcer

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

This study aims to assess topical MEBO application on pain relief and wound healing.

NCT ID: NCT06135688 Completed - Lidocaine Clinical Trials

Effects of Lidocaine Bolus and Infusion on Bispectral Index Values and Spectrum During Anesthesia Maintenance

Start date: November 18, 2023
Phase:
Study type: Observational

Lidocaine has been shown to increase the hypnotic effects of Propofol, however no trials shows the effects on Bispectral Index Values (BIS) and spectral analysis during total intravenous anesthesia maintenance delivered with target controlled infusion (TCI) with stable Concnetration at the effector site of Propofol (CeP)

NCT ID: NCT05935449 Completed - Lidocaine Clinical Trials

The Clinical Trial of Difference Between Formaderm Lidocaine and Formaderm Dermal Filler Injection

Start date: August 4, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and efficacy of Formaderm Lidocaine to the correction of nasolabial folds wrinkle and reduction of pain immediately after treatment. The main questions it aims to answer are: 1. The pain score assessed using Visual Analog Pain Scale(VAS) and Thermometer Pain Scale(TPS). 2. The facial wrinkle assessed using Wrinkle Severity Rating Scales(WSRS). 3. The treatment improvement assessed using Global Aesthetic Improvement Scale (GAIS). 4. Safety Indicators of which incidences on the day of the injection or after the injection. Participants will be self-controlled and randomized for same period, - received both trial product and control product at the same time. - re-visited on Day 14 and Day 30 after injection. The researchers will compare whether Formaderm Lidocaine is superior to Formaderm Dermal Filler Injection (without lidocaine) in terms of pain relief experienced by subjects during injection.

NCT ID: NCT05690087 Completed - Lidocaine Clinical Trials

Lidocaine Infusion on Optic Nerve Sheath Diameter in Laparoscopic Hysterectomy in Trendelenburg Position

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

We hypothesize that intravenous lidocaine infusion may have beneficial effect to patients undergoing laparoscopic surgeries in Trendelenburg position by preventing ICP elevation.

NCT ID: NCT05484687 Completed - Lidocaine Clinical Trials

Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors

Start date: March 24, 2020
Phase: N/A
Study type: Interventional

Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Surgical resection is the main treatment option for colorectal cancer patients. Surgery may enhance or accelerate tumor recurrence and metastasis. Multiple factors in the tumor microenvironment play important roles in tumor recurrence and metastasis, and modulating the tumor microenvironment can inhibit disease progression. Lidocaine has been found to inhibit tumor growth in animal experiments.

NCT ID: NCT04706767 Completed - Dexmedetomidine Clinical Trials

Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery

Start date: January 28, 2021
Phase: N/A
Study type: Interventional

BACKGROUND: Some studies have revealed that intravenous (IV) lidocaine or dexmedetomidine might improve the quality of recovery undergoing laparoscopic surgery. The investigators investigated whether co-administration lidocaine and dexmedetomidine could better improve the the quality of recovery after laparoscopic total hysterectomy. METHODS: One hundred and forty-four women with elective laparoscopic total hysterectomy were randomly divided into four groups: Patients in group L received a bolus infusion of lidocaine (2%; 1.5 mg/kg over 10 min before the induction of anesthesia), and then lidocaine was infused at a rate of 1.5 mg/kg/h until close the pneumoperitoneum. Patients in group D received a bolus infusion of dexmedetomidine (0.5 µg/kg over 10 min before the induction of anesthesia), and then dexmedetomidine was infused at a rate of 0.4 μg/kg/h until close the pneumoperitoneum. Patients in group LD received a bolus infusion of lidocaine (2%; 1.5 mg/kg) and dexmedetomidine (0.5 µg/kg) over 10 min before the induction of anesthesia, and then lidocaine and dexmedetomidine were infused at a rate of 1.5 mg/kg/h and 0.4 µg/kg/h until close the pneumoperitoneum, respectively. Patients in group C received the same volume of normal saline 10 min before the induction of anesthesia, and then normal saline (0.9%) was continuously infused in an equal volume until close the pneumoperitoneum. Primary outcome was the quality of recovery (QoR-40) at 1 day prior to sugery, 1 day after sugery, and 2 days after sugery. The secondary outcomes included perioperative remifentanil consumption, postoperative VAS scores, the incidence of postoperative nausea and vomiting, postoperative rescue analgesics and anti-emetics, recovery time, extubation time, and Ramsay sedation scale at 5 min, 10min, 30 min, 60 min after extubation.

NCT ID: NCT04692896 Completed - Lidocaine Clinical Trials

Effect of Different Concentrations of Lidocaine in Relieving Pain in Wide Awake Hand Surgery Using Tumescence

Start date: September 1, 2017
Phase: Phase 1
Study type: Interventional

Lidocaine has been used along with adrenaline in tumescent anesthesia for a variety of procedures. This has been quite popular especially in wide awake surgery of the hand with no tourniquet. However, the appropriate lidocaine concentration is yet to be established. This randomized control trial will study the minimum effective lidocaine concentration in hand surgery using the tumescent technique.

NCT ID: NCT04622085 Completed - Lidocaine Clinical Trials

The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face

Start date: April 6, 2021
Phase: N/A
Study type: Interventional

This study is to evaluate the safety and effectiveness for the correction of aging mid-face of treatment group compared with the active control group.

NCT ID: NCT04599335 Completed - Lidocaine Clinical Trials

The Evaluation of the Safety and Effectiveness of a Novel Gel-type Sodium Hyaluronate for the Correction of Aging Mid-face

Start date: April 6, 2021
Phase: N/A
Study type: Interventional

This study is to evaluate the safety and effectiveness for the correction of aging mid-face of treatment group compared with the negative control group.